BELGRADE, Mont., Feb. 24, 2012 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, will release its financial results for the three and 12 months ended December 31, 2011 after the close of regular market trading on Thursday, March 22, 2012. A conference call will follow at 4:30 p.m. Eastern Time ( 1:30 p.m. Pacific Time). Conference Call Details:Date: Thursday, March 22, 2012Time: 4:30 p.m. Eastern time ( 1:30 p.m. Pacific time)Dial-In Number: 1-877-941-1427 International: 1-480-629-9664Conference ID#: 4519974The conference call will be broadcast simultaneously and available for replay here and at the investor section of the company's Web site at http://www.bacterin.com/index.htm.Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Hayden IR at 1-646-755-7412. A replay of the call will be available after 7:30 p.m. Eastern time on the same day and until April 22, 2012. International replay number: 1-858-384-5517Replay pin number: 4519974About Bacterin International Holdings Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.